The Pennant Group, Inc. · NASDAQ:PNTG
Steik Jason Paul sold 218 The Pennant Group, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Steik Jason Paul (Chief Clinical Officer) sold 218 The Pennant Group, Inc. shares at US$37.15 for US$8,098 under a trading plan, leaving 14,888 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 218 shares
- Price
- US$37.15
- Value
- US$8,098
- Holding after
- 14,888 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Clinical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 218 | US$37.15 | 14,888 | Direct |
Source
Download original · View original at SEC
Related
- The Pennant Group, Inc.
- Steik Jason Paul
- The Pennant Group, Inc. shareholders
- Form 4 · Steik Jason Paul · Aug 10, 2026
- Form 4 · Smith Barry M · Nov 13, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Oct 30, 2026
- Form 4 · Gochnour John J · Oct 27, 2026
- Form 4 · Covey Stephen M R · Oct 19, 2026
- Form 4 · Morris Gregory K Sr. · Oct 19, 2026